Phenotypic and genotypic diversity of human neuroblastoma studied in three IGR cell line models derived from bone marrow metastases

Cancer Genetics and Cytogenetics

Volumn 112, Issue 2, 1999, Pages 124-129

  Valent, Alexander ^a   Bénard, Jean ^a   Vénuat, Anne Marie ^a   Da Silva, Jacqueline ^a   Duverger, Annette ^a   Duarte, Nathalie ^a   Hartmann, Olivier ^a   Spengler, Barbara A ^b   Bernheim, Alain ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b FORDHAM UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW; BONE MARROW METASTASIS; CASE REPORT; CELL LINE; CELL TYPE; CONTROLLED STUDY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; KARYOTYPE; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; STROMA CELL;

BONE NEOPLASMS; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; NEUROBLASTOMA; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0344849466     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00264-7     Document Type: Article

References (19)

1. Evans A., D'Angio G., Propert K., Anderson J., Hann H.W. Prognostic factors in neuroblastoma. Cancer. 59:1987;1853-1859.
2. Shimada H., Chatten J., Newton W. Histopathologic prognostic factors in neuroblastic tumors. definition of subtypes of ganglioneuroblastoma and age-linked classification of neuroblastoma J Natl Cancer Inst. 73:1984;405-416.
3. Brodeur G.M., Fong C.T., Morita M., Griffith R., Hayes F.A., Seeger R.C. Molecular analysis and clinical significance of N-myc amplification and chromosome 1 abnormalities in human neuroblastomas. Prog Clin Biol Res. 271:1988;3-15.
4. Schwab M., Alitalo K., Klempnauer K.H., Varmus H., Bishop J.M., Gilbert F., Brodeur G., Goldstein M., Trent J. Amplified DNA domain with limited homology to the myc cellular oncogene is shared by human neuroblastoma cell lines and a human neuroblastoma tumor. Nature. 305:1983;245-248.
5. Kogner P., Barbany G., Dominici C., Castello M.A., Raschella G., Persson H. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res. 53:1993;2044-2050.
6. Meddeb M., Danglot G., Chudoba I., Vénuat A.M., Bénard J., Avet-Loiseau H., Vasseur B., Le Paslier D., Hartmann O., Bernheim A. Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas. Genes Chromosom Cancer. 17:1996;156-165.
7. Lastowska M., Roberts P., Pearson A.D.J., Lewis I., Wolstenholme J., Bown N. Promiscuous translocations of chromosome arm 17q in human neuroblastomas. Genes Chromosom Cancer. 19:1997;143-149.
8. Brodeur G.M. Molecular basis for heterogeneity in human neuroblastomas. Eur J Cancer. 31A:1995;505-510.
9. Ambros I.M., Zellner A., Roald B., Amann G., Ladenstein R., Printz D., Gadner H., Ambros P.F. Role of ploidy, chromosome 1p and Schwann cells in the maturation of neuroblastoma. N Engl J Med. 334:1996;1505-1511.
10. Ferrandis E., Da Silva J., Riou G., Bénard J. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mice. Cancer Res. 54:1994;2256-2261.
11. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
12. Bourhis J., De Vathaire F., Wilson G.D., Hartmann O., Terrier-Lacombe M.J., Boccon-Gibod L., McNally N.J., Lemerle J., Riou G., Bénard J. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res. 51:1991;33-36.
13. Biedler J.L., Spengler B.A., Chang T.D., Ross R.A. Transdifferentiation of human neuroblastoma cells result in coordinate loss of neuronal and malignant properties. Prog Clin Biol Res. 271:1988;265-276.
14. Ross R.A., Spengler B.A., Biedler J.L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst. 71:1983;741-747.
15. Ciccarone V., Spengler B.A., Meyers M.B., Biedler J.L., Ross R.A. Phenotypic diversification in human neuroblastoma cells. expression of distinct neural crest lineages Cancer Res. 49:1989;219-225.
16. Biedler J.L., Spengler B.A., Ross R.A. Cellular maturation and oncogene expression during drug induced differentiation in vitro. a brief review Ragaz J., Simpson-Herren L., Lippman M.E., Fisher B. Effects of Therapy on Biology and the Kinetics of the Residual Tumor, Part A. Pre-Clinical Aspects:1990;287-312 Wiley-Liss, New York.
17. Ross R.A., Spengler B.A., Domènech C., Porubcin M., Rettig W.J., Biedler J.L. Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ. 6:1995;449-456.
18. Spengler B.A., Lazarova D.L., Ross R.A., Biedler J.L. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells. Oncol Res. 9:1997;467-476.
19. Weiss W.A., Aldape A., Mohapatra G., Feurstein B.G., Bishop J.M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 16:1997;2985-2995.